Infliximab in the treatment of posterior uveitis in Behçet's disease: Long term follow up in four patients

Presse Medicale

Volumn 34, Issue 13, 2005, Pages 916-918

  Lanthier, Nicolas ^a   Parc, Christine ^a   Scavennec, Rodolphe ^a   Dhôte, Robin ^b   Brézin, Antoine P ^a   Guillevin, Loïc ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; INFLIXIMAB; MEPREDNISONE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; VALACICLOVIR;

ADJUVANT THERAPY; ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

EID: 23044509893     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(05)84079-5     Document Type: Article

References (8)

1. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
2. Sfikakis PP. Behçet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 2002; 61: 51-3.
3. Santos Lacomba M, Marcos Martin C, Gallardo Galera JM et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 2001; 33: 251-5.
4. Kaklamani VG, Kaklamanis PG. Treatment of Behçet's disease: an update. Semin Arthritis Rheum 2001; 30: 299-312.
5. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet 2001; 358: 295-6.
6. Joseph A, Raj D, Dua HS, Powell PT, Lanyon PC, Powell RJ. Infliximab in the treatment of refractory posterior uveitis. Ophthalmology 2003; 110: 1449-53.
7. Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D. Tumor necrosis factor blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 2004; 111: 352-6.
8. Wechsler B, Sablé-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I et al. Infliximab in refractory uveitis due to Behçet disease. Clin Exp Rheumatol 2004; 22:S14-16.